Found: 8
Select item for more details and to access through your institution.
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1484, doi. 10.3390/cells9061484
- By:
- Publication type:
- Article
Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00319
- By:
- Publication type:
- Article
Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 9, p. 1984, doi. 10.1002/ijc.22929
- By:
- Publication type:
- Article
UGT2B17 modifies drug response in chronic lymphocytic leukaemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of combined spa-exercise therapy on circulating TGF-β1 levels in patients with ankylosing spondylitis.
- Published in:
- Wiener Klinische Wochenschrift, 2006, v. 118, n. 7/8, p. 266, doi. 10.1007/s00508-006-0560-y
- By:
- Publication type:
- Article
Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia ( CLL) cells.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 5, p. 618, doi. 10.1111/bjh.12183
- By:
- Publication type:
- Article
NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 6, p. 868, doi. 10.1111/j.1365-2141.2009.08024.x
- By:
- Publication type:
- Article
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 10, p. 2408, doi. 10.1002/cncr.22263
- By:
- Publication type:
- Article